000 | 01864 a2200577 4500 | ||
---|---|---|---|
005 | 20250517044759.0 | ||
264 | 0 | _c20160808 | |
008 | 201608s 0 0 eng d | ||
022 | _a1097-0223 | ||
024 | 7 |
_a10.1002/pd.4668 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGrömminger, Sebastian | |
245 | 0 | 0 |
_aThe influence of low molecular weight heparin medication on plasma DNA in pregnant women. _h[electronic resource] |
260 |
_bPrenatal diagnosis _cNov 2015 |
||
300 |
_a1155-7 p. _bdigital |
||
500 | _aPublication Type: Letter; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAnticoagulants _xtherapeutic use |
650 | 0 | 4 |
_aBlood Specimen Collection _xmethods |
650 | 0 | 4 |
_aChromosome Disorders _xdiagnosis |
650 | 0 | 4 | _aChromosomes, Human, Pair 13 |
650 | 0 | 4 | _aChromosomes, Human, Pair 18 |
650 | 0 | 4 | _aCytosine |
650 | 0 | 4 |
_aDNA _xblood |
650 | 0 | 4 |
_aDiagnostic Errors _xprevention & control |
650 | 0 | 4 |
_aDown Syndrome _xdiagnosis |
650 | 0 | 4 | _aFalse Positive Reactions |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGuanosine |
650 | 0 | 4 |
_aHeparin, Low-Molecular-Weight _xtherapeutic use |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aPlasma |
650 | 0 | 4 | _aPregnancy |
650 | 0 | 4 | _aPrenatal Diagnosis |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 |
_aTrisomy _xdiagnosis |
650 | 0 | 4 | _aTrisomy 13 Syndrome |
650 | 0 | 4 | _aTrisomy 18 Syndrome |
700 | 1 | _aErkan, Sanli | |
700 | 1 | _aSchöck, Ulrike | |
700 | 1 | _aStangier, Kerstin | |
700 | 1 | _aBonnet, Joachim | |
700 | 1 | _aSchloo, Rüdiger | |
700 | 1 | _aSchubert, Angela | |
700 | 1 | _aPrott, Eva-Christina | |
700 | 1 | _aKnoll, Ute | |
700 | 1 | _aStumm, Markus | |
700 | 1 | _avon Kalle, Christof | |
700 | 1 | _aHofmann, Wera | |
773 | 0 |
_tPrenatal diagnosis _gvol. 35 _gno. 11 _gp. 1155-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/pd.4668 _zAvailable from publisher's website |
999 |
_c25145391 _d25145391 |